Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tranexamic acid to prevent hematoma and swelling after carpal tunnel release surgery
IRCT201605242115N4Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in carpal tunnel syndrome (CTS), sponsored by Kerman University of Medical Sciences. Primary endpoints: Postoperative hematoma formation and Postoperative swelling. Started Oct 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT201605242115N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201605242115N4.